Raymond James Financial Services Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $729K | Buy |
17,189
+494
| +3% | +$21K | ﹤0.01% | 2376 |
|
|
2024
Q2 | $673K | Buy |
16,695
+681
| +4% | +$27.4K | ﹤0.01% | 2333 |
|
|
2024
Q1 | $567K | Buy |
16,014
+169
| +1% | +$5.98K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $469K | Sell |
15,845
-1,950
| -11% | -$57.7K | ﹤0.01% | 2465 |
|
|
2023
Q3 | $370K | Sell |
17,795
-1,351
| -7% | -$28.1K | ﹤0.01% | 2502 |
|
|
2023
Q2 | $470K | Sell |
19,146
-7,134
| -27% | -$175K | ﹤0.01% | 2377 |
|
|
2023
Q1 | $1.07M | Buy |
26,280
+7,850
| +43% | +$319K | ﹤0.01% | 1863 |
|
|
2022
Q4 | $828K | Sell |
18,430
-743
| -4% | -$33.4K | ﹤0.01% | 1962 |
|
|
2022
Q3 | $917K | Sell |
19,173
-445
| -2% | -$21.3K | ﹤0.01% | 1856 |
|
|
2022
Q2 | $1.16M | Sell |
19,618
-594
| -3% | -$35.2K | ﹤0.01% | 1741 |
|
|
2022
Q1 | $2.35M | Sell |
20,212
-10,480
| -34% | -$1.22M | ﹤0.01% | 1394 |
|
|
2021
Q4 | $4.62M | Buy |
30,692
+8,224
| +37% | +$1.24M | 0.01% | 1050 |
|
|
2021
Q3 | $2.68M | Buy |
22,468
+14,352
| +177% | +$1.71M | 0.01% | 1314 |
|
|
2021
Q2 | $790K | Sell |
8,116
-637
| -7% | -$62K | ﹤0.01% | 2100 |
|
|
2021
Q1 | $772K | Buy |
8,753
+2,021
| +30% | +$178K | ﹤0.01% | 2022 |
|
|
2020
Q4 | $644K | Sell |
6,732
-3,403
| -34% | -$326K | ﹤0.01% | 1981 |
|
|
2020
Q3 | $1.15M | Buy |
10,135
+441
| +5% | +$50K | ﹤0.01% | 1475 |
|
|
2020
Q2 | $959K | Buy |
+9,694
| New | +$959K | ﹤0.01% | 1515 |
|
|
2020
Q1 | – | Sell |
-3,509
| Closed | -$209K | – | 2775 |
|
|
2019
Q4 | $209K | Sell |
3,509
-46
| -1% | -$2.74K | ﹤0.01% | 2545 |
|
|
2019
Q3 | $210K | Sell |
3,555
-5,560
| -61% | -$328K | ﹤0.01% | 2467 |
|
|
2019
Q2 | $588K | Buy |
9,115
+3,961
| +77% | +$256K | ﹤0.01% | 1819 |
|
|
2019
Q1 | $327K | Buy |
+5,154
| New | +$327K | ﹤0.01% | 2179 |
|
|
2018
Q4 | – | Sell |
-7,798
| Closed | -$334K | – | 2784 |
|
|
2018
Q3 | $334K | Buy |
+7,798
| New | +$334K | ﹤0.01% | 2204 |
|